Patent Infringement Litigation Pharmaceutical Patents Patent Disputes Patent Law Video Game Patents Infringement Patent Examination Patent Litigation Design Patents Patent Dispute Inventorship US Patent and Trademark Office Technology Patents Trade Regulations Gaming Patents Bayh-Dole Act Copyrights AI Patents Patent Reexamination Injunctions Automotive Patents Regulations Agricultural Patents Biotechnology Software Patents Patent Rejection Patent Eligibility Patent Applications Licensing Inter Partes Review Competition Law Patent Offices Patent Search HIV Prevention Drug Regimens AI Innovations Invention Violation Blood Oximeter Patent Dispute Resolution Ex Parte Reexamination America Invents Act AI Inventor AI University Compliance Masimo Patents Orange Book Patent Enforcement Communication Protocols Semaglutida Patent Provisional Patents Re-examination Biopiracy UK Patent Law Disputes Video Games Amendments Examination Process Computer-Implemented Inventions Patent Cooperation Treaty Trademark Issues Generic Drugs International Standards Pulse Oximetry Correcting Errors Patent Invalidation Conflict Resolution AI Inventions Healthcare UK Federal Circuit IPR and PGR Proceedings Legal Disputes Patent Violation Patent Revocation International Patents AI Innovation Patent Violations Copyright Infringement Food Classification UK Supreme Court Application Procedures Patent Controversies Computer-Related Inventions Prosecution Prior Art Patent Infringement Lawsuit Gaming Law Patent Lawsuits Medical Patents Blood Oxygen Patents International Federal Legislation Cultural Terms Legal Protection Game Patents Patent Duration Patent Maintenance Patent Filing Process Lawsuits
The unanimous June 4 ruling limits disgorgement to a wrongdoer’s net profits and resolves a split over whether the SEC must show investors suffered pecuniary harm.
